Biomarin Pharmaceutical Inc (BMRN)
Operating return on assets (Operating ROA)
| Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating income (ttm) | US$ in thousands | 187,212 | 161,154 | 122,435 | 94,357 | 74,639 | 149,562 | 108,182 | 57,380 | 29,900 | -82,341 | -67,976 | -70,698 | -123,315 | -43,440 | -1,087 | 58,864 | 58,455 | -100,457 | -129,443 | -149,194 |
| Total assets | US$ in thousands | 6,872,670 | 6,841,600 | 6,758,160 | 6,563,170 | 6,433,700 | 6,375,070 | 6,264,040 | 6,145,840 | 6,062,710 | 6,004,770 | 5,977,480 | 5,898,500 | 5,805,050 | 5,848,020 | 6,158,090 | 5,302,110 | 4,722,840 | 4,690,040 | 4,558,130 | 4,393,380 |
| Operating ROA | 2.72% | 2.36% | 1.81% | 1.44% | 1.16% | 2.35% | 1.73% | 0.93% | 0.49% | -1.37% | -1.14% | -1.20% | -2.12% | -0.74% | -0.02% | 1.11% | 1.24% | -2.14% | -2.84% | -3.40% |
March 31, 2024 calculation
Operating ROA = Operating income (ttm) ÷ Total assets
= $187,212K ÷ $6,872,670K
= 2.72%
Operating return on assets (ROA) is a key financial ratio that measures a company's ability to generate operating profits from its assets. Biomarin Pharmaceutical Inc's operating ROA has shown fluctuation over the past several quarters.
In the most recent quarter, as of March 31, 2024, the operating ROA stood at 2.72%, showing an improvement compared to the previous quarter. This indicates that Biomarin Pharmaceutical Inc is generating $2.72 in operating income for every $100 of assets it holds.
The trend in operating ROA over the past year has been somewhat volatile, with fluctuations observed from positive to negative figures. This volatility may be a reflection of changes in operating efficiency, profitability, or asset utilization within the company.
It is important for Biomarin Pharmaceutical Inc to closely monitor its operating ROA performance and assess the factors influencing this ratio. By identifying opportunities to enhance operational efficiency and profitability, the company can strive to maintain a sustainable level of return on its asset base.
Peer comparison
Mar 31, 2024